View in EDS HTML Full Text PDF Full Text

CLK-dependent exon recognition and conjoined gene formation revealed with a novel small molecule inhibitor.

Saved in:
Bibliographic Details
Title: CLK-dependent exon recognition and conjoined gene formation revealed with a novel small molecule inhibitor.
Authors: Funnell T; Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, V6T 2B5., Tasaki S; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Oloumi A; Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, V6T 2B5.; Janssen Pharmaceuticals, Toronto, Ontario, Canada., Araki S; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Kong E; Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, V6T 2B5., Yap D; Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, V6T 2B5., Nakayama Y; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Hughes CS; Michael Smith Genome Sciences Centre, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3., Cheng SG; Michael Smith Genome Sciences Centre, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3., Tozaki H; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Iwatani M; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Sasaki S; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Ohashi T; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Miyazaki T; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Morishita N; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Morishita D; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Ogasawara-Shimizu M; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Ohori M; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Nakao S; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Karashima M; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Sano M; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Murai A; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Nomura T; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Uchiyama N; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Kawamoto T; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Hara R; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.; Fujirebio Inc., Tokyo, Japan., Nakanishi O; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.; Department of Innovative Drug Discovery and Development, Japan Agency for Medical Research and Development, Osaka, Japan., Shumansky K; Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, V6T 2B5., Rosner J; Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, V6T 2B5.; Advanced Research Computing, University of British Columbia, Vancouver, British Columbia, Canada., Wan A; Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, V6T 2B5., McKinney S; Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, V6T 2B5., Morin GB; Michael Smith Genome Sciences Centre, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3.; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada, V6H 3N1., Nakanishi A; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Shah S; Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, V6T 2B5., Toyoshiba H; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan. hiroyoshi.toyoshiba@takeda.com., Aparicio S; Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3. saparicio@bccrc.ca.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, V6T 2B5. saparicio@bccrc.ca.
Source: Nature communications [Nat Commun] 2017 Feb 23; Vol. 8 (1), pp. 7. Date of Electronic Publication: 2017 Feb 23.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 28232751
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CLK-dependent exon recognition and conjoined gene formation revealed with a novel small molecule inhibitor.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Funnell+T%22">Funnell T</searchLink>; Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, V6T 2B5.<br /><searchLink fieldCode="AU" term="%22Tasaki+S%22">Tasaki S</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.<br /><searchLink fieldCode="AU" term="%22Oloumi+A%22">Oloumi A</searchLink>; Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, V6T 2B5.; Janssen Pharmaceuticals, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Araki+S%22">Araki S</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.<br /><searchLink fieldCode="AU" term="%22Kong+E%22">Kong E</searchLink>; Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, V6T 2B5.<br /><searchLink fieldCode="AU" term="%22Yap+D%22">Yap D</searchLink>; Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, V6T 2B5.<br /><searchLink fieldCode="AU" term="%22Nakayama+Y%22">Nakayama Y</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.<br /><searchLink fieldCode="AU" term="%22Hughes+CS%22">Hughes CS</searchLink>; Michael Smith Genome Sciences Centre, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3.<br /><searchLink fieldCode="AU" term="%22Cheng+SG%22">Cheng SG</searchLink>; Michael Smith Genome Sciences Centre, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3.<br /><searchLink fieldCode="AU" term="%22Tozaki+H%22">Tozaki H</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.<br /><searchLink fieldCode="AU" term="%22Iwatani+M%22">Iwatani M</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.<br /><searchLink fieldCode="AU" term="%22Sasaki+S%22">Sasaki S</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.<br /><searchLink fieldCode="AU" term="%22Ohashi+T%22">Ohashi T</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.<br /><searchLink fieldCode="AU" term="%22Miyazaki+T%22">Miyazaki T</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.<br /><searchLink fieldCode="AU" term="%22Morishita+N%22">Morishita N</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.<br /><searchLink fieldCode="AU" term="%22Morishita+D%22">Morishita D</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.<br /><searchLink fieldCode="AU" term="%22Ogasawara-Shimizu+M%22">Ogasawara-Shimizu M</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.<br /><searchLink fieldCode="AU" term="%22Ohori+M%22">Ohori M</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.<br /><searchLink fieldCode="AU" term="%22Nakao+S%22">Nakao S</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.<br /><searchLink fieldCode="AU" term="%22Karashima+M%22">Karashima M</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.<br /><searchLink fieldCode="AU" term="%22Sano+M%22">Sano M</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.<br /><searchLink fieldCode="AU" term="%22Murai+A%22">Murai A</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.<br /><searchLink fieldCode="AU" term="%22Nomura+T%22">Nomura T</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.<br /><searchLink fieldCode="AU" term="%22Uchiyama+N%22">Uchiyama N</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.<br /><searchLink fieldCode="AU" term="%22Kawamoto+T%22">Kawamoto T</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.<br /><searchLink fieldCode="AU" term="%22Hara+R%22">Hara R</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.; Fujirebio Inc., Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Nakanishi+O%22">Nakanishi O</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.; Department of Innovative Drug Discovery and Development, Japan Agency for Medical Research and Development, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Shumansky+K%22">Shumansky K</searchLink>; Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, V6T 2B5.<br /><searchLink fieldCode="AU" term="%22Rosner+J%22">Rosner J</searchLink>; Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, V6T 2B5.; Advanced Research Computing, University of British Columbia, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Wan+A%22">Wan A</searchLink>; Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, V6T 2B5.<br /><searchLink fieldCode="AU" term="%22McKinney+S%22">McKinney S</searchLink>; Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, V6T 2B5.<br /><searchLink fieldCode="AU" term="%22Morin+GB%22">Morin GB</searchLink>; Michael Smith Genome Sciences Centre, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3.; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada, V6H 3N1.<br /><searchLink fieldCode="AU" term="%22Nakanishi+A%22">Nakanishi A</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.<br /><searchLink fieldCode="AU" term="%22Shah+S%22">Shah S</searchLink>; Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, V6T 2B5.<br /><searchLink fieldCode="AU" term="%22Toyoshiba+H%22">Toyoshiba H</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan. hiroyoshi.toyoshiba@takeda.com.<br /><searchLink fieldCode="AU" term="%22Aparicio+S%22">Aparicio S</searchLink>; Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3. saparicio@bccrc.ca.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, V6T 2B5. saparicio@bccrc.ca.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2017 Feb 23; Vol. 8 (1), pp. 7. <i>Date of Electronic Publication: </i>2017 Feb 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28232751
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-016-0008-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 7
    Titles:
      – TitleFull: CLK-dependent exon recognition and conjoined gene formation revealed with a novel small molecule inhibitor.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Funnell T
      – PersonEntity:
          Name:
            NameFull: Tasaki S
      – PersonEntity:
          Name:
            NameFull: Oloumi A
      – PersonEntity:
          Name:
            NameFull: Araki S
      – PersonEntity:
          Name:
            NameFull: Kong E
      – PersonEntity:
          Name:
            NameFull: Yap D
      – PersonEntity:
          Name:
            NameFull: Nakayama Y
      – PersonEntity:
          Name:
            NameFull: Hughes CS
      – PersonEntity:
          Name:
            NameFull: Cheng SG
      – PersonEntity:
          Name:
            NameFull: Tozaki H
      – PersonEntity:
          Name:
            NameFull: Iwatani M
      – PersonEntity:
          Name:
            NameFull: Sasaki S
      – PersonEntity:
          Name:
            NameFull: Ohashi T
      – PersonEntity:
          Name:
            NameFull: Miyazaki T
      – PersonEntity:
          Name:
            NameFull: Morishita N
      – PersonEntity:
          Name:
            NameFull: Morishita D
      – PersonEntity:
          Name:
            NameFull: Ogasawara-Shimizu M
      – PersonEntity:
          Name:
            NameFull: Ohori M
      – PersonEntity:
          Name:
            NameFull: Nakao S
      – PersonEntity:
          Name:
            NameFull: Karashima M
      – PersonEntity:
          Name:
            NameFull: Sano M
      – PersonEntity:
          Name:
            NameFull: Murai A
      – PersonEntity:
          Name:
            NameFull: Nomura T
      – PersonEntity:
          Name:
            NameFull: Uchiyama N
      – PersonEntity:
          Name:
            NameFull: Kawamoto T
      – PersonEntity:
          Name:
            NameFull: Hara R
      – PersonEntity:
          Name:
            NameFull: Nakanishi O
      – PersonEntity:
          Name:
            NameFull: Shumansky K
      – PersonEntity:
          Name:
            NameFull: Rosner J
      – PersonEntity:
          Name:
            NameFull: Wan A
      – PersonEntity:
          Name:
            NameFull: McKinney S
      – PersonEntity:
          Name:
            NameFull: Morin GB
      – PersonEntity:
          Name:
            NameFull: Nakanishi A
      – PersonEntity:
          Name:
            NameFull: Shah S
      – PersonEntity:
          Name:
            NameFull: Toyoshiba H
      – PersonEntity:
          Name:
            NameFull: Aparicio S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 02
              Text: 2017 Feb 23
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1